XML 36 R25.htm IDEA: XBRL DOCUMENT v3.24.3
NATURE OF BUSINESS & SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
9 Months Ended
Sep. 30, 2024
Accounting Policies [Abstract]  
Schedule of Stock by Class Share information related to the Company's common stock as of September 30, 2024, is as follows:
Class A Common StockClass B Common StockTotal Common Stock
Authorized210,000,00090,000,000300,000,000
Issued26,866,9043,112,51629,979,420
Outstanding26,429,6303,112,51629,542,146
Schedule of Deferred Revenue Activity

The following table represents the deferred revenue activity for the nine months ended September 30, 2024:

In ThousandsDeferred Revenue
Balance as of December 31, 2023$1,210 
Consideration earned(3,050)
Consideration received2,922 
Balance as of September 30, 2024$1,082 
The following table represents the deferred revenue activity for the nine months ended September 30, 2023:
In ThousandsDeferred Revenue
Balance as of December 31, 2022$107 
Acquired from merger with Cibus Global, LLC1,186 
Consideration earned(714)
Consideration received1,058 
Balance as of September 30, 2023$1,637 
Schedule of Computation of Basic and Diluted Net Loss Per Share The following table shows the computation of basic and diluted net loss per share of Class A Common Stock for the three and nine months ended September 30, 2024, and 2023:
Three Months Ended September 30,Nine Months Ended September 30,
In Thousands, Except Share and Per Share Amounts2024202320242023
Numerator:
Net loss attributable to Cibus, Inc.$(179,968)$(26,429)$(228,286)$(50,513)
Denominator:
Weighted average shares of Class A common stock outstanding23,536,74616,641,12722,055,9797,979,132
Effect of pre-funded warrants50,00050,000
Weighted average shares of Class A common stock outstanding – basic and diluted23,586,74616,641,12722,105,9797,979,132
Basic and diluted net loss per share of Class A common stock$(7.63)$(1.59)$(10.33)$(6.33)
Schedule of Antidilutive Securities Excluded from Computation of Loss Per Share The following potential dilutive securities, presented on an as converted basis, were excluded from the calculation of net loss per share of Class A Common Stock due to their antidilutive effect:
As of September 30,
20242023
Stock options outstanding150,899109,551
Unvested restricted stock units115,541198,199
Unvested restricted stock awards392,097945,780
Common warrants1,456,523158,483
Total2,115,0601,412,013